{"id":"W4392481691","doi":"10.1016/j.ebiom.2024.105043","title":"A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies","year":2024,"lang":"en","type":"article","venue":"EBioMedicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"H2020 Marie Skłodowska-Curie Actions; Astellas Pharma; Oncolytics Biotech; Incyte; Gilead Sciences; GlaxoSmithKline; Fundación Científica Asociación Española Contra el Cáncer; Veracyte; Daiichi Sankyo Europe; European Commission; Breast Cancer Research Foundation; Instituto de Salud Carlos III; Amgen; Pfizer; Les Laboratories Pierre Fabre; Fundación Fero; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Triple-negative breast cancer; Medicine; Oncology; Internal medicine; Breast cancer; Immune system; Cohort; Stage (stratigraphy); Survival analysis; Proportional hazards model; Cancer; Immunology; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006007858,0.0003087626,0.001201319,0.001526036,0.00004008388,0.00001211875,0.0001439966,0.0001668914,0.0007395124],"category_scores_gemma":[0.00004926829,0.0002175961,0.0003909674,0.005158102,0.0003456225,0.00008743804,0.00005293389,0.0003905483,0.000006091769],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003627734,"about_ca_system_score_gemma":0.000243855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003104599,"about_ca_topic_score_gemma":0.0005525116,"domain_scores_codex":[0.9978425,0.00008113452,0.0007435218,0.0004718196,0.0005043308,0.0003567],"domain_scores_gemma":[0.9989398,0.0002043693,0.0001721152,0.0003779235,0.000202697,0.000103055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01047728,0.000858208,0.01041949,0.002018509,0.03865682,0.001395843,0.04218555,0.00005893226,0.864334,0.00002581704,0.004832457,0.02473712],"study_design_scores_gemma":[0.03231319,0.002527723,0.7983065,0.006541185,0.01808516,0.0001012018,0.01486846,0.002637507,0.1145278,0.00009483148,0.008868151,0.001128236],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8917767,0.1002527,0.00003831622,0.005598414,0.0006748034,0.0006646577,0.0005471049,0.00007891849,0.0003683458],"genre_scores_gemma":[0.986528,0.004871132,0.00007446058,0.0004547798,0.0002231276,0.00007669429,0.0001034789,0.00003668074,0.007631592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7878871,"threshold_uncertainty_score":0.8873312,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01436953566838358,"score_gpt":0.3121454258346046,"score_spread":0.297775890166221,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}